达安基因

- 002030

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
达安基因(002030) 利润表
单位:万元
报表日期2025-03-312024-12-312024-09-302024-06-302024-03-31
一、营业总收入16,913.6685,302.4359,105.0140,038.1419,830.77
营业收入16,913.6685,302.4359,105.0140,038.1419,830.77
二、营业总成本23,817.58105,806.4569,578.0045,431.2320,795.15
营业成本11,663.9853,274.3435,475.0223,534.978,758.12
营业税金及附加95.74953.40421.25278.69122.32
销售费用4,535.4620,813.5310,581.026,299.582,541.90
管理费用3,156.2414,705.2511,168.126,805.635,341.44
财务费用-1,028.62-6,506.89-4,780.84-3,378.17-1,608.76
研发费用5,394.7922,566.8316,713.4311,890.535,640.12
资产减值损失----------
公允价值变动收益20,072.73-17,574.58-11,922.41-30,686.12-36,557.29
投资收益-2,475.27-25,383.81-13,010.87-2,996.06-2,209.61
其中:对联营企业和合营企业的投资收益-2,613.57-27,133.07-14,510.44-4,514.40-2,586.42
汇兑收益----------
三、营业利润9,317.68-106,760.55-56,676.21-47,473.73-43,330.69
加:营业外收入79.31258.4243.6812.8412.65
减:营业外支出14.07614.21155.24140.6788.77
其中:非流动资产处置损失----------
四、利润总额9,382.92-107,116.34-56,787.76-47,601.56-43,406.81
减:所得税费用4,256.64-13,205.05-6,637.60-7,836.98-7,292.72
五、净利润5,126.28-93,911.29-50,150.16-39,764.58-36,114.09
归属于母公司所有者的净利润5,292.43-92,516.99-50,271.97-39,921.91-36,329.06
少数股东损益-166.14-1,394.30121.82157.32214.98
六、每股收益
基本每股收益(元/股)0.0400-0.6600-0.3582-0.2800-0.2589
稀释每股收益(元/股)0.0400-0.6600-0.3582-0.2800-0.2589
七、其他综合收益-3.84-330.9312.5848.5122.05
八、综合收益总额5,122.44-94,242.21-50,137.57-39,716.07-36,092.04
归属于母公司所有者的综合收益总额5,290.19-92,866.17-50,255.70-39,877.40-36,306.70
归属于少数股东的综合收益总额-167.75-1,376.04118.13161.33214.67
下载全部历史数据到excel中 返回页顶